Navigation Links
Boston Scientific Announces Release of Next-Generation iLab(R) System Software
Date:9/21/2009

NATICK, Mass., Sept. 21 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) today announced release of its CE-Marked, next-generation iLab System Software for the iLab(R) Ultrasound Imaging System. Intravascular Ultrasound (IVUS) technology is designed to provide physicians a 360-degree view inside the heart and coronary vessels to assist with diagnosis and to allow a more accurate representation of the diseased vessels than is possible with angiography alone. The iLab software upgrade includes functionality designed to improve diagnosis and save time. The principal new feature of the system, iMap(TM), provides a detailed color analysis of plaque composition within the targeted areas.

"The upgraded iLab software, featuring iMap tissue characterization, offers detailed plaque information that may help physicians treat coronary artery disease," said Prof. Patrick W. Serruys, M.D., Ph.D., Chief of Interventional Cardiology, Thoraxcenter-Erasmus University, Rotterdam. "The combination of Boston Scientific's 40MHz catheter and the new characterization algorithm represents the latest generation of IVUS imaging technology."

In addition to iMap, the iLab software includes features such as Modality Worklist Management, which allows a physician to access a patient's profile from the hospital server and view it on the iLab System monitor. Additional features include an on-screen print icon and the ability to edit and save video images of a procedure directly to CD, DVD or hard drive. The iLab software is currently in a global limited market release with full commercial availability planned for later this year in all regions.

iMap software is not currently approved for sale in the U.S.

Boston Scientific is a worldwide developer, m
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Boston Scientific to Explore Sale of Cardiac Surgery and Vascular Surgery Businesses
2. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
3. Boston Scientific Amends Credit Facility and Prepays $1 Billion on Loan
4. Boston Scientific to Participate in the Bear Stearns 20th Annual Healthcare Conference
5. Revolutionary Genomics Research Group Opens Boston Office; Provides DNA Evidence in Workers Comp Cases
6. Boston Scientific Announces Election of Ray Elliott to Its Board of Directors
7. Alliance for Medical Devices, Instrumentation and Diagnostics formed between Fraunhofer Center for Manufacturing Innovation and Boston University
8. Boston Scientific Releases Remote Monitoring Data from its Wireless LATITUDE(R) Patient Management System
9. Genzyme Begins Major Expansion of Boston Manufacturing Facility
10. New Scientists Boost Disease-based Research at Boston Biomedical Research Institute
11. Boston Scientific to Webcast Conference Call Discussing Third Quarter Financial Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...ecember 2 , - "Bolstering...ritage" , Coinciding with the Internation...e Republic is hosting an international conference ... biological resources in Africa. The,conference wi...nisters,scientific experts, private companies, re...
(Date:12/2/2009)...PRNewswire/ -- S*BIO Pte Ltd today announced data ...1518, at The American Society of Hematology 51st A... Data will be presented on the clinical results fr...ailing its safety, tolerability and pharmacokineti...anging from 100 to 600 mg. These doses were admini...
(Date:12/2/2009)...PRNewswire-Asia/ -- The world is going through,ext...tainty is part of many,businesses and industries. ...atively immune to the economic downturn, because i...the midst of the difficult times this year, the ph...ed an R&D center in Shanghai, the largest of,i...
(Date:12/1/2009).... 1 PDL BioPharma, Inc. ...dance for the fourth quarter ended December 31, 20...$69 million for the fourth quarter of 2008. Includ... two installment payments of $12.5 million from Al...ts was a one-time $1.8 million payment from Genent...
Breaking Biology Technology:Libreville International Conference 2-3 June 2010 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 2Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 3PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 2PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 3
... Taiwan, 1950-2000, Celebrates Important...torian John R. Watt, Ph.D. is Editor of a Comprehe... Health Services in Taiwan, ABMAC Foundation Opens...m Worth Studying, NEW...,Bureau for Medical Advancement in China, today re...
...cialization of Recently FDA-cleared ... Calif., Sept. 4 Pathwork Diagnostics, a,molecula...ed the closing,today of a $20 million financing le...s of FDA,s clearance for the Pathwork(R) Tissue of...origin, including poorly,differentiated, undiffere...
...sdaq:,INSM) a developer of follow-on biologics and... Allan, Ph.D., CEO of Insmed, will present at the,...scussing Insmed,s,experiences to date regarding th...s (FOB) in the U.S. His presentation will take pla...wers Hotel in Singapore., This year,s BioPharm As...
Other Biology Technology:ABMAC Foundation Announces Publication of an Historic Volume Documenting the Creation of a National Health Care System in Taiwan 2ABMAC Foundation Announces Publication of an Historic Volume Documenting the Creation of a National Health Care System in Taiwan 3Pathwork Diagnostics Closes $20M Financing 2Insmed to Present at BioPharm Asia 2008 Conference 2
(Date:12/2/2009)...oke for a prolonged period of time and in high qua... in women who never smoked cigarettes themselves. ...eam smoke could increase risk of breast cancer is ...., senior research scientist at the Northern Calif...ingle epidemiologic study can answer the question,...
(Date:12/2/2009)...in forest,s woodland herb population has shown tha...es recover from logging, according to Purdue Unive...ons of the forest nearly 80 years ago, the distrib...loor was similar to that of undisturbed areas. Mic...stry and natural resources, said that contrasts wi...
(Date:12/2/2009)...a College of Veterinary Medicine have made an "une...s for treating Ichthyophthirius multifiliis, or "I...e that commonly attacks freshwater fish. , With ...und that Ich harbors two apparently symbiotic intr...y found free-living, and Rickettsia, which are obl...
Breaking Biology News(10 mins):Exposure to secondhand cigarette smoke over a lifetime increased breast cancer risk later in life 2Study finds logging effects vary based on a forest's history, climate 2UGA researchers lead team in discovery involving devastating freshwater fish parasite, 'Ich' 2UGA researchers lead team in discovery involving devastating freshwater fish parasite, 'Ich' 3InteKrin Therapeutics Appoints Linda Slanec Higgins PhD Chief Operating Officer 57107 1InteKrin Therapeutics Appoints Linda Slanec Higgins PhD Chief Operating Officer 57107 2Seasoned Insurance and Managed Care Senior Executive Joins Connextions Inc Board of Directors 57104 1Seasoned Insurance and Managed Care Senior Executive Joins Connextions Inc Board of Directors 57104 2Seasoned Insurance and Managed Care Senior Executive Joins Connextions Inc Board of Directors 57104 3BioLife Solutions Announces HypoThermosol 28R 29 and CryoStor 28TM 29 Distribution Agreement With Sigma Aldrich 14030 1BioLife Solutions Announces HypoThermosol 28R 29 and CryoStor 28TM 29 Distribution Agreement With Sigma Aldrich 14030 2BioLife Solutions Announces HypoThermosol 28R 29 and CryoStor 28TM 29 Distribution Agreement With Sigma Aldrich 14030 3
... Journal of the American Dietetic Association fe...ating habits of consumers. Researchers look at why...nd methods for adding healthier foods to a person,... Journal of the American Dietetic Association inc...d Reasons among Frequent Consumers, Menu Modeling ...
...Research Hospital have discovered that a certain d...identity that it requires the constant expression ...earchers showed that Prox1 acts as a two-way switc...ecialized type of cell, called a lymphatic endothe...he LEC actually loses its identity and assumes cha...
...tight junction protein called claudin 11 makes the... be published in the December 1, 2008 issue of the...e the rubber coating on a copper wire, the myelin ...rals around the axons of neuronscreates an insulat... and aids electrical conduction along the length o...
Other Biology News:News from the December 2008 Journal of the American Dietetic Association 2Reprogrammable cell type depends on a single gene to keep its identity 2
Dulbecco's Phosphate Buffered Saline (DPBS) from Sigma-Aldrich
...es provide a fast, easy to use, reproducible and r...are 15 times faster and 5 times more accurate (mar...able the determination of the packed cell volume (...ata correlating with parameters like protein conte...
Illumina Custom Data Analysis Report from Asuragen, Inc.
DKW/Juglans Basal Salt Mixture from Sigma-Aldrich
Biology Products: